Mitochondrial dysfunction in Parkinson's disease

Cites (326)

Items 201–325 of 325

1. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin–protein ligase with monoubiquitylation capacity
   Cornelia Hampe, Héctor Ardila-Osorio, Margot Fournier, Alexis Brice, Olga Corti · 2006 · Human Molecular Genetics
2. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin
   Sathya R. Sriram, Xiaojie Li, Han Seok Ko, Kenny K. K. Chung, Esther S.P. Wong, Kah Leong Lim, Valina Lynn Dawson, Ted M. Dawson · 2005 · Human Molecular Genetics
3. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes
   Benecke, R., Strumper, P., Weiss, H. · 1993 · Brain
4. Mice lacking alpha-synuclein are resistant to mitochondrial toxins
   Péter Klivènyi, Donald F. Siwek, Gabrielle Gardian, Lichuan Yang, Anatoly A. Starkov, Carine Cléren, Robert J. Ferrante, Neil W. Kowall, Asa Abeliovich, M. Flint Beal · 2005 · Neurobiology of Disease
5. Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction
   Jeehye Park, Sung Yun Kim, Guang‐Ho Cha, Sung Bae Lee, Sunhong Kim, Jongkyeong Chung · 2005 · Gene
6. The genetics of Parkinson's syndromes: a critical review
   John Hardy, Patrick Alfryn Lewis, Tamás Révész, Andrew John Lees, Coro Paisán‐Ruiz · 2009 · Current Opinion in Genetics & Development
7. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells
   Mordhwaj Singh Parihar, Arti Parihar, Masayo Fujita, Makoto Hashimoto, Pedram Ghafourifar · 2009 · The International Journal of Biochemistry & Cell Biology
8. Optical Reporters for the Conformation of α-Synuclein Reveal a Specific Interaction with Mitochondria
   Ken Nakamura, Venu M. Nemani, Erika K. Wallender, Katrin Kaehlcke, Mélanie Ott, Robert H. Edwards · 2008 · Journal of Neuroscience
9. Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations.
   Lysia S. Forno, Louis E. DeLanney, Ian Irwin, J. William Langston · 1993 · PubMed
10. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease
    Bernd Janetzky, Sabine Hauck, Moussa B. H. Youdim, Peter Franz Riederer, K. A. Jellinger, Felix Pantucek, Robert Zo ̈chling, Kurt W. Boissl, Heinz Reichmann · 1994 · Neuroscience Letters
11. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function
    Cheng Wang, Han Seok Ko, Bobby Thomas, Fai Tsang, Katherine C. M. Chew, Shiam-Peng Tay, Michelle W. L. Ho, T. M. Lim, Tuck Wah Soong, Olga Pletniková et al. · 2005 · Human Molecular Genetics
12. Energy-Linked Reduction of Mitochondrial Pyridine Nucleotide
    Britton Chance, Gunnar Hollunger · 1960 · Nature
13. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
    Hans-Hermann Hoepken, Suzana Gispert, Blas Morales, Oliver Wingerter, Domenico Del Turco, Alexander Mülsch, Robert Luke Nussbaum, Klaus Müller, Stefan Dröse, Ulrich Brandt et al. · 2006 · Neurobiology of Disease
14. Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells
    Gegg, Matthew E., Cooper, J. Mark, Schapira, Anthony H. V., Taanman, Jan-Willem · 2009 · PLoS ONE
15. Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity
    Sarah J. Tabrizi · 2000 · Human Molecular Genetics
16. Multiple pathways for mitochondrial protein traffic
    T. Endo, Koji Yamano · 2009 · Biological chemistry
17. Roles of Drosophila DJ-1 in Survival of Dopaminergic Neurons and Oxidative Stress
    Fiona M. Menzies, Sarat Chandra Yenisetti, Kyung‐Tai Min · 2005 · Current Biology
18. Parkin Mediates Neuroprotection through Activation of IκB Kinase/Nuclear Factor-κB Signaling
    Iris H. Henn, Lena Bouman, Julia S. Schlehe, Anita Schlierf, Julia E. Schramm, Elmar Wegener, Kazuhiro Nakaso, Carsten Culmsee, Benedikt Berninger, Daniel Krappmann et al. · 2007 · Journal of Neuroscience
19. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson’s disease factors Pink1 and Parkin
    Alexander J. Whitworth, Jeffrey R. Lee, Venus M.-W. Ho, Robert Flick, Ruhena B. Chowdhury, G. Angus McQuibban · 2008 · Disease Models & Mechanisms
20. Parkin genetics: one model for Parkinson's disease
    Ignacio Fernandez Mata · 2004 · Human Molecular Genetics
21. Mitochondrial translocation of α-synuclein is promoted by intracellular acidification
    Nelson B. Cole, Diane DiEuliis, Paul Leo, Drake C. Mitchell, Robert Luke Nussbaum · 2008 · Experimental Cell Research
22. Diverse Effects of Pathogenic Mutations of Parkin That Catalyze Multiple Monoubiquitylation in Vitro
    Noriyuki Matsuda, Toshiaki Kitami, Toshiaki Suzuki, Yoshikuni Mizuno, Nobutaka Hattori, Keiji Tanaka · 2005 · Journal of Biological Chemistry
23. The PINK1–Parkin pathway is involved in the regulation of mitochondrial remodeling process
    Jeehye Park, Gina Lee, Jongkyeong Chung · 2008 · Biochemical and Biophysical Research Communications
24. Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage
    Christine C. Stichel, Xin‐Ran Zhu, Verian Bader, Bettina Linnartz‐Gerlach, S. Schmidt, Hermann Lübbert · 2007 · Human Molecular Genetics
25. Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair
    Oliver C. Rothfuss, Heike Fischer, Takafumi Hasegawa, Martina Maisel, Petra Leitner, Franziska Miesel, Manu Sharma, Antje Bornemann, Daniela Berg, Thomas Gasser et al. · 2009 · Human Molecular Genetics
26. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases
    Wim J. Mandemakers, Vanessa A. Morais, Bart De Strooper · 2007 · Journal of Cell Science
27. Mitochondrial Alterations in PINK1 Deficient Cells Are Influenced by Calcineurin-Dependent Dephosphorylation of Dynamin-Related Protein 1
    Anna Matton, Kelly Jean Thomas Craig, Alexandra G. Beilina, Marcel van der Brug, Megan Cleland Harwig, Rili Ahmad, David W. Miller, Ibardo Zambrano, Richard F. Cowburn, Homira Behbahani et al. · 2009 · PLoS ONE
28. Parkinson’s disease: genetic versus toxin‐induced rodent models
    Mügen Terzioglu, Dagmar Galter · 2008 · FEBS Journal
29. Cell systems and the toxic mechanism(s) of α-synuclein
    Mark Cookson, Marcel van der Brug · 2007 · Experimental Neurology
30. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress
    Miratul M. K. Muqit, Patrick M. Abou‐Sleiman, Adrian Thomas Saurin, Kirsten Harvey, Sonia Gandhi, Emma Deas, Simon D. Eaton, Martin D. Payne Smith, Kerrie Venner, Antoni Matilla‐Dueñas et al. · 2006 · Journal of Neurochemistry
31. Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1
    Andreas Weihofen, Beth L. Ostaszewski, Yasufumi Minami, Dennis J. Selkoe · 2007 · Human Molecular Genetics
32. Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease
    H. Fai Poon, Mark A. Frasier, Nathan Shreve, Vittorio Calabrese, Benjamin L. Wolozin, David Allan Butterfield · 2005 · Neurobiology of Disease
33. Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells
    Shavali Shaik, Holly M. Brown‐Borg, Manuchair Ebadi, James E. Porter · 2008 · Neuroscience Letters
34. Mendelian forms of Parkinson's disease
    Thomas Gasser · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
35. RING finger 1 mutations in Parkin produce altered localization of the protein
    Mark Cookson · 2003 · Human Molecular Genetics
36. Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress
    Hong Mei Li, Takeshi Niki, Takahiro Taira, Sanae M.M. Iguchi‐Ariga, Hiroyoshi Ariga · 2005 · Free Radical Research
37. Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function
    Magali Periquet, Olga Corti, Sandrine Jacquier, Alexis Brice · 2005 · Journal of Neurochemistry
38. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Rosario Moratalla, Bruce Quinn, Louis E. DeLanney, Ian Irwin, J. William Langston, Ann M. Graybiel · 1992 · Proceedings of the National Academy of Sciences
39. Apamin-sensitive Ca2+-activated K+ channels regulate pacemaker activity in nigral dopamine neurons
    Han Ping, Donald S. Shepard · 1996 · Neuroreport
40. Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y
    Hao Deng, Joseph J. Jankovic, Yi Guo, Wenjie Xie, Weidong Le · 2005 · Biochemical and Biophysical Research Communications
41. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson’s disease by disturbing calcium flux
    Roberta Marongiu, Brian J. Spencer, Leslie A. Crews, Anthony Adame, Christina Patrick, Margarita Trejo, Bruno Dallapiccola, Enza Maria Valente, Eliezer Masliah · 2009 · Journal of Neurochemistry
42. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline
    Marı́a José Casarejos, J. Menéndez, Rosa Maria Solano, José Antonio Rodríguez‐Navarro, Justo Garcı́a de Yébenes, M. A. Mena · 2006 · Journal of Neurochemistry
43. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ‐synuclein, α‐synuclein and double α/γ‐synuclein null mutant mice
    Darren C. Robertson, Oliver Schmidt, Natalia N. Ninkina, Paul A. Jones, John Sharkey, Vladimir L. Buchman · 2004 · Journal of Neurochemistry
44. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease
    Luoma, P. T., Eerola, J., Ahola, S., Hakonen, A. H., Hellström, O., Kivistö, K. T., Tienari, P. J., Suomalainen, A. · 2007 · Neurology
45. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
    Andreas Hartmann, Patrick Pierre Michel, Jean‐Denis Troadec, Annick Prigent, Baptiste A. Faucheux, Merle Ruberg, Yves Agid, Étienne C. Hirsch · 2001 · Journal of Neurochemistry
46. Mitochondrial DNA Mutations in Disease, Aging, and Neurodegeneration
    Amy Katherine Reeve, Kim J. Krishnan, Douglass M. Turnbull · 2008 · Annals of the New York Academy of Sciences
47. Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
    Oliver M. Schlüter, Francesco Fornai, M. Alessandri, Saika TAKAMORI, Martin Geppert, Reinhard Jahn, Thomas Christian Südhof · 2003 · Neuroscience
48. Oxidizable Residues Mediating Protein Stability and Cytoprotective Interaction of DJ-1 with Apoptosis Signal-regulating Kinase 1
    Jens Waak, Stephanie S. Weber, Karin Görner, Christoph Schall, Hidenori Ichijo, Thilo Stehle, Philipp J. Kahle · 2009 · Journal of Biological Chemistry
49. Inactivation of Parkin by Oxidative Stress and C-terminal Truncations
    Konstanze F. Winklhofer, Iris H. Henn, Penelope C. Kay-Jackson, Ulrich Heller, Jörg Tatzelt · 2003 · Journal of Biological Chemistry
50. Functional Mitochondria Are Required for α-Synuclein Toxicity in Aging Yeast
    Sabrina Büttner, Alessandro Bitto, Julia Ring, Manuela Augsten, Piotr Zabrocki, Tobias Eisenberg, Helmut Jungwirth, Sylvia Hütter, Didac Carmona‐Gutiérrez, Guido Kroemer et al. · 2008 · Journal of Biological Chemistry
51. Mitochondrial dynamics in Parkinson's disease
    Victor S. Van Laar, Sarah Berman · 2009 · Experimental Neurology
52. Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson?s disease
    Vincenzo Bonifati, Ben A. Oostra, Peter Heutink · 2004 · Journal of Molecular Medicine
53. PINK1 Defect Causes Mitochondrial Dysfunction, Proteasomal Deficit and α-Synuclein Aggregation in Cell Culture Models of Parkinson's Disease
    Wencheng Liu, Cristòfol Vives-Bauzá, Rebeca Acín‐Pérez, Ai Yamamoto, Ying-cai Tan, Yanping Li, Jordi Magrané, Mihaela A. Stavarache, Sebastian Shaffer, Simon H. Chang et al. · 2009 · PLoS ONE
54. Oxidative insults induce DJ-1 upregulation and redistribution: Implications for neuroprotection
    Nirit Lev, Debby Ickowicz, Eldad Melamed, Daniel Offen · 2008 · NeuroToxicology
55. Nature of Mitochondrial DNA Deletions in Substantia Nigra Neurons
    Amy Katherine Reeve, Kim J. Krishnan, Joanna L. Elson, Christopher M. Morris, Andreas Bender, Robert Neil Lightowlers, Douglass M. Turnbull · 2008 · The American Journal of Human Genetics
56. Mitochondrial alterations in Parkinson’s disease: new clues
    Miquel Vila, David Ramonet, Céline Perier · 2008 · Journal of Neurochemistry
57. Semi-quantitative analysis of α-synuclein in subcellular pools of rat brain neurons: An immunogold electron microscopic study using a C-terminal specific monoclonal antibody
    Ling Zhang, Chunyan Zhang, Yuangang Zhu, Qing Cai, Piu Chan, Kenji Uéda, Shun Yu, Hui Yang · 2008 · Brain Research
58. Sensitivity to MPTP is not increased in Parkinson's disease‐associated mutant α‐synuclein transgenic mice: RAPID COMMUNICATION
    Rathke‐Hartlieb, Silvia, Kahle, Philipp J., Neumann, Manuela, Ozmen, Laurence, Haid, Sibylle, Okochi, Masayasu, Haass, Christian, Schulz, Jörg B. · 2001 · Journal of Neurochemistry
59. α-Synuclein and Parkin Contribute to the Assembly of Ubiquitin Lysine 63-linked Multiubiquitin Chains
    Ellen Doss-Pepe, Li Chen, Kiran Madura · 2005 · Journal of Biological Chemistry
60. Creation and Characterization of Mitochondrial DNA‐Depleted Cell Lines with “Neuronal‐Like” Properties
    Scott W. Miller, Patricia A. Trimmer, William Davis Parker, Robert E. Davis · 1996 · Journal of Neurochemistry
61. DJ-1 and Parkin Modulate Dopamine-dependent Behavior and Inhibit MPTP-induced Nigral Dopamine Neuron Loss in Mice
    Jean‐Charles Paterna, Andreas Leng, Elisabeth Weber, Joram Feldon, Hansruedi Büeler · 2007 · Molecular Therapy
62. Leucine‐rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
    Payal N. Gandhi, Shu G. Chen, Amy L. Wilson‐Delfosse · 2008 · Journal of Neuroscience Research
63. Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease‐linked point mutations
    Cheng Wang, Jeanne M.M. Tan, Michelle W. L. Ho, Norazean Zaiden, Siew Heng Wong, Constance L. C. Chew, Pei Woon Eng, Tit Meng Lim, Ted M. Dawson, Kah Leong Lim · 2005 · Journal of Neurochemistry
64. Parkin: a multifaceted ubiquitin ligase
    Darren J. Moore · 2006 · Biochemical Society Transactions
65. Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1
    Sho Takatori, Genta Ito, Takeshi Iwatsubo · 2007 · Neuroscience Letters
66. Parkin Protects against Neurotoxicity in the 6-Hydroxydopamine Rat Model for Parkinson's Disease
    Linda Vercammen, Anke Van der Perren, Elisabetta Vaudano, Rik Gijsbers, Zeger Debyser, Chris Van den Haute, Veerle Baekelandt · 2006 · Molecular Therapy
67. Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in parkinson's disease
    Marina Varastet, DANIELLE RICHE, M. Mazière, Philippe Hantraye · 1994 · Neuroscience
68. Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls
    Javier Simón‐Sánchez, Andrew Singleton · 2008 · Human Molecular Genetics
69. Physiological and pathological properties of α-synuclein
    George K. Tofaris, M. G. Spillantini · 2007 · Cellular and Molecular Life Sciences
70. Mice Lacking α-Synuclein have an Attenuated Loss of Striatal Dopamine Following Prolonged Chronic MPTP Administration
    Robert E. Drolet, Bahareh Behrouz, Keith J. Lookingland, John L. Goudreau · 2004 · NeuroToxicology
71. Parkin attenuates manganese‐induced dopaminergic cell death
    Youichirou Higashi, Masato Asanuma, Ikuko Miyazaki, Nobutaka Hattori, Yoshikuni Mizuno, Norio Ogawa · 2004 · Journal of Neurochemistry
72. Mitochondrial DNA mutations and aging: devils in the details?
    Khrapko, Konstantin, Vijg, Jan · 2009 · Trends in Genetics
73. Genetic variability in the mitochondrial serine proteaseHTRA2contributes to risk for Parkinson disease
    Veerle Bogaerts, Karen Nuytemans, Joke Reumers, Philippe Pals, Sebastiaan Engelborghs, Barbara Anne Pickut, Ellen Corsmit, Karin Peeters, Joost W. H. Schymkowitz, Peter Paul De Deyn et al. · 2008 · Human Mutation
74. Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology
    Anne Grünewald, Matthew E. Gegg, Jan‐Willem Taanman, Rosalind H.M. King, Norman Kock, Christine Klein, Anthony H.V. Schapira · 2009 · Experimental Neurology
75. Pathogenic mutations inactivate parkin by distinct mechanisms
    Iris H. Henn, Johanna Maria Gostner, Peter Lackner, Jörg Tatzelt, Konstanze F. Winklhofer · 2004 · Journal of Neurochemistry
76. Parkinsonism genes: culprits and clues
    Asa Abeliovich, M. Flint Beal · 2006 · Journal of Neurochemistry
77. Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons
    Philippe Hantraye, Marina Varastet, Marc Peschanski, DANIELLE RICHE, Pierre Césaro, Willer Jc, M. Mazière · 1993 · Neuroscience
78. Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
    Saskia Biskup, Andrew B. West · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
79. Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation
    Cláudia Piccoli, Anna Maria Sardanelli, Rosella Scrima, Maria Cristina Ripoli, Giovanni Quarato, Annamaria D’Aprile, Francesco Bellomo, Salvatore Scacco, Giuseppe De Michele, Alessandro Filla et al. · 2008 · Neurochemical Research
80. Mechanistic aspects of Parkinson’s disease: α-synuclein and the biomembrane
    Klaus Beyer · 2007 · Cell Biochemistry and Biophysics
81. Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice
    Weiwei Yang, L. Chen, Yunmin Ding, Xiaoxi Zhuang, Un Jung Kang · 2007 · Human Molecular Genetics
82. Parkin expression in the adult mouse brain
    Christine C. Stichel, Martin A. Augustin, Kati Kühn, Xin‐Ran Zhu, Peter Engels, Christoph Ullmer, Hermann Lübbert · 2000 · European Journal of Neuroscience
83. Biochemical aspects of the neuroprotective mechanism of PTEN‐induced kinase‐1 (PINK1)
    Ryan D. Mills, Chou Hung Sim, Su San Mok, Terrence D. Mulhern, Janetta Gladys Culvenor, Heung‐Chin Cheng · 2008 · Journal of Neurochemistry
84. Phosphorylation and cleavage of presenilin-associated rhomboid-like protein (PARL) promotes changes in mitochondrial morphology
    Danny V. Jeyaraju, Liqun Xu, Marie-Claude Letellier, Sirisha Bandaru, Rodolfo Zunino, Eric A. Berg, Heidi May McBride, Luca Pellegrini · 2006 · Proceedings of the National Academy of Sciences
85. Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin
    Luke Stephen Tain, Ruhena B. Chowdhury, Ran Tao, Hélène Plun‐Favreau, Nicoleta Moisoi, L. Miguel Martins, Julian Downward, Alexander J. Whitworth, Nicolas Tapon · 2009 · Cell Death and Differentiation
86. Genetics of parkin-linked disease
    Andrew B. West, Nigel T. Maidment · 2004 · Human Genetics
87. L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner
    Yasuhiro Moriwaki, Yeon‐Jeong Kim, Yukari Ido, Hidemi Misawa, Koichiro Kawashima, Shogo Endo, Ryōsuke Takahashi · 2008 · Neuroscience Research
88. Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress
    María Dolores Ledesma, Cristian A. Galván, Bianca Hellias, Carlos G. Dotti, Poul Henning Jensen · 2002 · Journal of Neurochemistry
89. Mammalian complex I: A regulable and vulnerable pacemaker in mitochondrial respiratory function
    Sergio Papa, Domenico De Rasmo, Salvatore Scacco, Anna Signorile, Zuzana Technikova-Dobrova, Giuseppe Palmisano, Anna Maria Sardanelli, Francesco Papa, Damiano Panelli, Raffaella Scaringi et al. · 2008 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
90. The effects of oxidative stress on parkin and other E3 ligases
    Matthew J. LaVoie, Giuseppe P. Cortese, Beth L. Ostaszewski, Michael G. Schlossmacher · 2007 · Journal of Neurochemistry
91. Models of Parkinson's disease
    Michael Orth, Sarah J. Tabrizi · 2003 · Movement Disorders
92. Relative Sensitivity of Parkin and Other Cysteine-containing Enzymes to Stress-induced Solubility Alterations
    Esther S.P. Wong, Jeanne M.M. Tan, Cheng Wang, Zhenshui Zhang, Shiam-Peng Tay, Norazean Zaiden, Han Seok Ko, Valina Lynn Dawson, Ted M. Dawson, Kah‐Leong Lim · 2007 · Journal of Biological Chemistry
93. Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?
    Veerle Bogaerts, Jessie Theuns, Christine Van Broeckhoven · 2007 · Genes Brain & Behavior
94. Loss-of-Function Analysis Suggests ThatOmi/HtrA2Is Not an Essential Component of thepink1/parkinPathwayIn Vivo
    Jina Yun, Joseph H. Cao, Mark W. Dodson, Ira E. Clark, Pankaj Kapahi, Ruhena B. Chowdhury, Ming Guo · 2008 · Journal of Neuroscience
95. L-Type Calcium Channels Mediate a Slow Excitatory Synaptic Transmission in Rat Midbrain Dopaminergic Neurons
    Antonello Bonci, Pernilla Grillner, Nicola Biagio Mercuri, Giorgio Bernardi · 1998 · Journal of Neuroscience
96. The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates
    Wen‐Jie Gu, Olga Corti, Francisco Araujo, Cornelia Hampe, Sandrine Jacquier, Christoph B. Lücking, N. Abbas, Charles J. Duyckaerts, Thomas Rooney, Laurent Pradier et al. · 2003 · Neurobiology of Disease
97. Parkin Protects against Mitochondrial Toxins and β-Amyloid Accumulation in Skeletal Muscle Cells
    Kenneth M. Rosen, Vimal Veereshwarayya, Charbel Moussa, Qinghao Fu, Matthew S. Goldberg, Michael G. Schlossmacher, Jie Shen, Henry W. Querfurth · 2006 · Journal of Biological Chemistry
98. Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release
    Angela K. Berger, Giuseppe P. Cortese, Katherine D. Amodeo, Andreas Weihofen, Anthony G. Letai, Matthew J. LaVoie · 2009 · Human Molecular Genetics
99. Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle
    Andrew M. W. Penn, T. Roberts, J. Hodder, P. S. Allen, G. Zhu, W. R. Wayne Martin · 1995 · Neurology
100. Generation of Reactive Oxygen Species by Mitochondrial Complex I: Implications in Neurodegeneration
     Romana Fato, Christian Bergamini, Serena Leoni, Paola Strocchi, Giorgio Lenaz · 2008 · Neurochemical Research
101. Parkinson’s disease: a rethink of rodent models
     Melrose, Heather L., Lincoln, Sarah J., Tyndall, Glenn M., Farrer, Matthew J. · 2006 · Experimental Brain Research
102. Genetic variation of Omi/HtrA2 and Parkinson's disease
     Owen A. Ross, Alexandra I. Soto, Carles Vilariño‐Güell, Michael G. Heckman, Nancy N. Diehl, Mary Hulihan, Jan Olav Aasly, Sigrid Botne Sando, J. Mark Gibson, Timothy Lynch et al. · 2008 · Parkinsonism & Related Disorders
103. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease
     Fredric P. Manfredsson, Corinna Bürger, Layla F Sullivan, Nicholas Muzyczka, Alfred S. Lewin, Ronald J. Mandel · 2007 · Experimental Neurology
104. Signaling Functions of Free Radicals Superoxide & Nitric Oxide under Physiological & Pathological Conditions
     Igor B. Afanasʹev · 2007 · Molecular Biotechnology
105. Parkin stabilizes PINK1 through direct interaction
     Kahori Shiba, Takeo Arai, Shigeto Sato, Shinichiro Kubo, Yusuke Ohba, Yoshikuni Mizuno, Nobutaka Hattori · 2009 · Biochemical and Biophysical Research Communications
106. Emerging pathways in genetic Parkinson’s disease: Autosomal‐recessive genes in Parkinson’s disease – a common pathway?
     Julia C. Fitzgerald, H. Plun-Favreau · 2008 · The FEBS Journal
107. [Pyridine nucleotide in liver mitochondria. An analysis of their redox relationships].
     Martin Klingenberg, Werner Slenczka · 1959 · PubMed
108. A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease
     D.J. Taylor, David Krige, P. R. J. Barnes, Graham John Kemp, Maria T Carroll, Vincent M. Mann, J Allen D Cooper, C. DAVID MARSDEN, Anthony H.V. Schapira · 1994 · Journal of the Neurological Sciences
109. Molecular interaction between parkin and PINK1 in mammalian neuronal cells
     Ji Won Um, Christine C. Stichel-Gunkel, Hermann Lübbert, Gwang Lee, Kwang Chul Chung · 2009 · Molecular and Cellular Neuroscience
110. Effect of MPTP on Brain Mitochondrial H2O2 and ATP Production and on Dopamine and DOPAC in the Striatum
     Elodie Fabre, J. Monserrat, Asunción Herrero, Gustavo Barja, M.L. Leret · 1999 · Journal of Physiology and Biochemistry
111. Aberrant Folding of Pathogenic Parkin Mutants
     Julia S. Schlehe, A. Kathrin Lutz, Anna Pilsl, Kerstin Lämmermann, Katja Grgur, Iris H. Henn, Jörg Tatzelt, Konstanze F. Winklhofer · 2008 · Journal of Biological Chemistry
112. Transgenic rodent models of Parkinson’s disease
     B. K. Harvey, Y. Wang, Barry J. Hoffer · 2009 · Acta neurochirurgica. Supplementum
113. Genetics of parkinsonism
     Vincenzo Bonifati · 2007 · Parkinsonism & Related Disorders
114. Overexpression of Parkinson's disease‐associated α‐SynucleinA53T by recombinant adeno‐associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP
     Zhizhong Dong, Boris Ferger, Joram Feldon, Hansruedi Büeler · 2002 · Journal of Neurobiology
115. Effect of overexpression of wild‐type or mutant parkin on the cellular response induced by toxic insults
     Dong‐Hoon Hyun, MoonHee Lee, Barry B. Halliwell, Peter G. Jenner · 2005 · Journal of Neuroscience Research
116. Parkin mitochondria in the autophagosome
     Heidi May McBride · 2008 · The Journal of Cell Biology
117. DJ-1 and Parkin Modulate Dopamine-dependent Behavior and Inhibit MPTP-induced Nigral Dopamine Neuron Loss in Mice
     Jean‐Charles Paterna, Andreas Leng, Elisabeth Weber, Joram Feldon, Hansruedi Büeler · 2007 · Molecular Therapy
118. Animal models in neurodegenerative diseases
     Étienne C. Hirsch · 2007 · Springer eBooks
119. Cytoplasmic Transfer of Platelet mtDNA from Elderly Patients with Parkinson's Disease to mtDNA-less HeLa Cells Restores Complete Mitochondrial Respiratory Function
     Yuko Aomi, Chu-Shih Chen, Kazuto Nakada, Sayaka Ito, Kotoyo Isobe, Haruka Murakami, Shinya Kuno, Masato Tawata, Rumiko Matsuoka, Hidehiro Mizusawa et al. · 2001 · Biochemical and Biophysical Research Communications
120. Programmed cell death and new discoveries in the genetics of parkinsonism
     Robert E. Burke · 2008 · Journal of Neurochemistry
121. Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association
     Eng‐King Tan, Kim Yoong Puong, Daniel Kam Yin Chan, Kenneth Yew, Stephanie Man Chung Fook-Chong, Hui Shen, P. W. Ng, Jean Woo, Y. Yuen, R. Pavanni et al. · 2005 · Human Genetics
122. The parkin protein as a therapeutic target in Parkinson's disease
     Konstanze F. Winklhofer · 2007 · Expert Opinion on Therapeutic Targets
123. Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin‐proteasome system, and neuronal cell death in human neuroblastoma cells
     Elli Kyratzi, Maria Pavlaki, Dimitra P. Kontostavlaki, Hardy J. Rideout, Leonidas Stefanis · 2007 · Journal of Neurochemistry
124. The Role of Chaperones in Parkinson’s Disease and Prion Diseases
     Konstanze F. Winklhofer, Jörg Tatzelt · 2005 · Handbook of experimental pharmacology
125. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
     Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., Karluk, D. · 1999 · Annals of Neurology